Čeština | Dansk | Deutsch | English | Español | Français | Italiano | Nederlands | Norsk | Polski | Português | Pусский | Suomi | Svenska | US
Euro Huntington's disease network [logo]
Resumen de los artículos 2010 - 2011 -
Artículos científicos

La mayoría de los resúmenes de artículos presentes en esta sección han sido redactados por la escritora científica del EHDN, Diana Raffelsbauer, a petición del Comité Editorial del Boletín del EHDN.

El Grupo Europeo pretende informar a las personas interesadas en la enfermedad y a la comunidad de profesionales de la salud sobre los esfuerzos actuales y los logros conseguidos para encontrar una cura para la enfermedad de Huntington.
Comprehensive behavioral testing in the R6/2 mouse model of Huntington’s disease shows no benefit from CoQ10 or minocycline
Liliana B. Menalled et al.
application/pdfam01-jan2011-issue12-en 
A randomized, placebocontrolled trial of latrepirdine in Huntington‘s disease
Karl Kieburtz et al.
application/pdfam02-jan2011-issue12-en 
Cell loss in the motor and cingulate cortex correlates with symptomatology in Huntington’s disease
Doris C. V. Thu et al.
application/pdfam03-jan2011-issue12-en 
Observing Huntington’s disease: the European Huntington’s Disease Network’s REGISTRY
Michael Orth and the European Huntington‘s Disease Network
application/pdfam04-apr2011-issue13-en 
Biological and clinical changes in premanifest and early stage Huntington’s disease in the TRACKHD study: the 12-month longitudinal analysis
Sarah J. Tabrizi et al.
application/pdfam05-apr2011-issue13-en 
Matrix metalloproteinases are modifiers of huntingtin proteolysis and toxicity in Huntington’s disease
John P. Miller et al.
application/pdfam06-apr2011-issue13-en 
 
paragraph image

What is the impact of education on Huntington's disease?
Jose Luis López-Sendón et al.
application/pdfam07-jul2011-issue14-en 
Early changes in the hypothalamic region in prodromal Huntington disease revealed by MRI analysis
Charlotte Soneson et al.
application/pdfam08-jul2011-issue14-en 
An antisense CAG repeat transcript at the JPH3 locus mediates expanded polyglutamine protein toxicity in Huntington‘s diseaselike 2 mice
Brian Wilburn et al.
application/pdfam09-jul2011-issue14-en 
Discrepancies in reporting the CAG repeat lengths for Huntington’s disease
Oliver Quarrell et al.
application/pdfam10-jan2012-issue15-en 
Functional gene expression profiling in yeast implicates translational dysfunction in mutant huntingtin toxicity
Eran Tauber et al.
application/pdfam11-jan2012-issue15-en 
A natural antisense transcript at the Huntington’s disease repeat locus regulates HTT expression
Daniel W. Chung et al.
application/pdfam12-jan2012-issue15-en 
Pridopidine for the treatment of motor function in patients with Huntington’s disease (MermaiHD): a phase 3, randomised, doubleblind, placebo-controlled trial
Justo G. de Yébenes et al.
application/pdfam01-jan2012-issue15-en